AIM2 and hepatocellular carcinoma: Therefore, AIM2 has the ability to suppress HCC growth and metastasis via the Notch signaling pathway without reliance on inflammasome signaling, and additionally demonstrates a protective role by inhibiting EMT (Table 2, Figure 2).